Hyeonju Jo

Title: Hyeonju Jo: Innovator in Liver Disease Treatment

Introduction

Hyeonju Jo is a notable inventor based in Suwon, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. His innovative work has led to the development of a unique pharmaceutical composition aimed at addressing serious health issues.

Latest Patents

Hyeonju Jo holds a patent for a pharmaceutical composition designed for treating non-alcoholic fatty liver, non-alcoholic steatohepatitis, or hepatic fibrosis. The patent details a method that involves administering at least one component selected from the group consisting of an Ssu72 peptide, a polynucleotide encoding the Ssu72 peptide, and an expression vector comprising the polynucleotide. This invention represents a promising approach to preventing or treating liver diseases.

Career Highlights

Hyeonju Jo is associated with Curogen Technology Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to improving health outcomes for patients suffering from liver-related conditions.

Collaborations

Hyeonju Jo collaborates with talented individuals in his field, including Chang Woo Lee and Jin Kwan Lee. These partnerships enhance the innovative potential of his projects and contribute to the overall success of their endeavors.

Conclusion

Hyeonju Jo's contributions to the treatment of liver diseases through his patented innovations highlight his role as a significant figure in medical research. His work continues to pave the way for advancements in healthcare.